Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

The long duration of TB therapy, the high prevalence of HIV coinfection, and the growing prevalence of drug-resistant TB underscore the urgent need for more effective treatments.

Detalles Bibliográficos
Autores principales: Schluger, Neil, Karunakara, Unni, Lienhardt, Christian, Nyirenda, Thomas, Chaisson, Richard
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062480/
https://www.ncbi.nlm.nih.gov/pubmed/17988170
http://dx.doi.org/10.1371/journal.pmed.0040302
_version_ 1782137216956366848
author Schluger, Neil
Karunakara, Unni
Lienhardt, Christian
Nyirenda, Thomas
Chaisson, Richard
author_facet Schluger, Neil
Karunakara, Unni
Lienhardt, Christian
Nyirenda, Thomas
Chaisson, Richard
author_sort Schluger, Neil
collection PubMed
description The long duration of TB therapy, the high prevalence of HIV coinfection, and the growing prevalence of drug-resistant TB underscore the urgent need for more effective treatments.
format Text
id pubmed-2062480
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-20624802007-11-06 Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries Schluger, Neil Karunakara, Unni Lienhardt, Christian Nyirenda, Thomas Chaisson, Richard PLoS Med Policy Forum The long duration of TB therapy, the high prevalence of HIV coinfection, and the growing prevalence of drug-resistant TB underscore the urgent need for more effective treatments. Public Library of Science 2007-11 2007-11-06 /pmc/articles/PMC2062480/ /pubmed/17988170 http://dx.doi.org/10.1371/journal.pmed.0040302 Text en © 2007 Schluger et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Policy Forum
Schluger, Neil
Karunakara, Unni
Lienhardt, Christian
Nyirenda, Thomas
Chaisson, Richard
Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
title Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
title_full Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
title_fullStr Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
title_full_unstemmed Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
title_short Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
title_sort building clinical trials capacity for tuberculosis drugs in high-burden countries
topic Policy Forum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062480/
https://www.ncbi.nlm.nih.gov/pubmed/17988170
http://dx.doi.org/10.1371/journal.pmed.0040302
work_keys_str_mv AT schlugerneil buildingclinicaltrialscapacityfortuberculosisdrugsinhighburdencountries
AT karunakaraunni buildingclinicaltrialscapacityfortuberculosisdrugsinhighburdencountries
AT lienhardtchristian buildingclinicaltrialscapacityfortuberculosisdrugsinhighburdencountries
AT nyirendathomas buildingclinicaltrialscapacityfortuberculosisdrugsinhighburdencountries
AT chaissonrichard buildingclinicaltrialscapacityfortuberculosisdrugsinhighburdencountries

Ejemplares similares